Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001196282 | SCV001366859 | likely pathogenic | Breast-ovarian cancer, familial, susceptibility to, 2 | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. |
Ambry Genetics | RCV002375123 | SCV002687274 | pathogenic | Hereditary cancer-predisposing syndrome | 2020-06-24 | criteria provided, single submitter | clinical testing | The c.8792delA pathogenic mutation, located in coding exon 21 of the BRCA2 gene, results from a deletion of one nucleotide at nucleotide position 8792, causing a translational frameshift with a predicted alternate stop codon (p.N2931Ifs*6). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |